CGS
COGSTATE FPO [CGS]
Healthcare · ASX Small Cap
$2.1900 -4.4%
Updated 2026-03-02 · Scores refresh every scan
Appeared in 2 consecutive scans→ Score +0First seen: 2026-02-25
Score Breakdown
Technical55
Catalyst50
Sentiment50
Fundamental97
Momentum82
Risk Gate50
Active Signals
Bullish Signals
- Above-average volume (1.7x) on down day
- VPT accumulation divergence (bullish)
- Above 200-day MA (long-term uptrend)
- Cash positive / operating cashflow positive
- Moderate P/S ratio (7.0x)
- Moderate revenue growth (+12%)
- Piotroski F-Score strong (8/9)
- EPS estimates revised upward (+10pts)
- CANSLIM C: Positive EPS growth (16% QoQ)
- CANSLIM A: Moderate annual earnings growth (10%)
- CANSLIM I: Institutional ownership (20%)
- Strong return on equity (22%)
- Healthy profit margins (19%)
- Strong 12-1 momentum (+60%)
- Earnings momentum: 2 consecutive improvements
- Analyst EPS expectations rising (+33%)
- ASX200 bullish (+1.5% 5d)
- RBA cutting (+2pts)
- Trial readout: PHASE4 (est. 2016-01)
Risk Signals
- Insufficient sentiment data (defaulting to neutral)
- Neutral/mixed sentiment
Recent Catalysts
NONE Update - Notification of buy-back - CGS
NONE Update - Notification of buy-back - CGS
NONE Cogstate 1H26 Financial Results
LOW 1H25 Investor Presentation Materials
Recent ASX Announcements
| 2026-02-24 | Update - Notification of buy-back - CGS |
| 2026-02-23 | Update - Notification of buy-back - CGS |
| 2026-02-18 | 1H25 Investor Presentation Materials PRICE SENSITIVE |
| 2026-02-18 | Cogstate 1H26 Financial Results PRICE SENSITIVE |
| 2026-02-18 | App 4D and Financial Statements Half-Year Ended 31 Dec 2025 PRICE SENSITIVE |
Key Metrics
$392.9M
Market Cap
147K
Avg Volume
1.7x
Vol Ratio
$1.21 — $2.97
52-Week Range
0.0%
Short Interest
N/A
Cash Runway
22.5%
ROE
19.2%
Profit Margin
CANSLIM Analysis
| Factor | Rating | Detail | |
|---|---|---|---|
| C | Current EPS | weak | EPS Growth: 16% |
| A | Annual Earnings | weak | CAGR: 10% |
| N | New Highs / Catalysts | neutral | |
| S | Supply & Demand | neutral | Float: 70% |
| L | Leader vs Laggard | laggard | RS: -2 |
| I | Institutional Sponsorship | pass | Inst: 20% |
| M | Market Direction | pass | Bullish |
Sector: Healthcare
Ranked #18 of 119 · Sector avg: 51
View all Healthcare signals →